Bhardwaj R, Donohue M, Madonia J, Anderson M, Matschke K, Bertz R
Clin Transl Sci. 2024; 17(10):e70015.
PMID: 39348235
PMC: 11441388.
DOI: 10.1111/cts.70015.
Toyohara J, Tago T, Sakata M
EJNMMI Radiopharm Chem. 2024; 9(1):53.
PMID: 39042331
PMC: 11266321.
DOI: 10.1186/s41181-024-00285-9.
Mairinger S, Jackwerth M, Soukup O, Blaickner M, Decristoforo C, Nics L
EJNMMI Radiopharm Chem. 2024; 9(1):34.
PMID: 38683266
PMC: 11058743.
DOI: 10.1186/s41181-024-00265-z.
Roffel A, van Hoogdalem E
Front Pharmacol. 2024; 15:1369079.
PMID: 38562464
PMC: 10982362.
DOI: 10.3389/fphar.2024.1369079.
Luong T, Nielsen E, Falborg L, Kjaerulff M, Tolbod L, Sondergaard E
EJNMMI Radiopharm Chem. 2023; 8(1):12.
PMID: 37314530
PMC: 10267081.
DOI: 10.1186/s41181-023-00198-z.
Human Dose Assessment of Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data.
Amraee N, Alirezapour B, Hosntalab M, Yousefnia H
J Med Phys. 2023; 47(3):287-293.
PMID: 36684706
PMC: 9847008.
DOI: 10.4103/jmp.jmp_34_22.
Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity?.
Burt T, Roffel A, Langer O, Anderson K, DiMasi J
Clin Transl Sci. 2022; 15(6):1355-1379.
PMID: 35278281
PMC: 9199889.
DOI: 10.1111/cts.13269.
Cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy, a randomized controlled trial (CAPTURE) protocol.
Kingma R, de Jong I, Greuter M, Roemeling S
Trials. 2021; 22(1):805.
PMID: 34781993
PMC: 8591918.
DOI: 10.1186/s13063-021-05794-5.
Absorption, metabolism, excretion, and safety of [C]almonertinib in healthy Chinese subjects.
Zhou C, Xie L, Liu W, Zhang L, Zhou S, Wang L
Ann Transl Med. 2021; 9(10):867.
PMID: 34164501
PMC: 8184462.
DOI: 10.21037/atm-21-1606.
Pharmacokinetic Study of Oral C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor.
Liao J, Wang X, Li Z, Ouyang D
Front Pharmacol. 2021; 12:665372.
PMID: 34122085
PMC: 8194275.
DOI: 10.3389/fphar.2021.665372.
Evaluation of a low-dose protocol for cone beam computed tomography of the temporomandibular joint - ethical and methodological considerations.
de Oliveira Reis L, Rosado L, Gaeta-Araujo H, Freitas D
Dentomaxillofac Radiol. 2020; 50(1):20200424.
PMID: 33216661
PMC: 7780830.
DOI: 10.1259/dmfr.20200424.
Effective dose in medicine.
Martin C
Ann ICRP. 2020; 49(1_suppl):126-140.
PMID: 33147998
PMC: 7750662.
DOI: 10.1177/0146645320927849.
Effects of axial load on in vivo scaphoid and lunate kinematics using four-dimensional computed tomography.
Brinkhorst M, Streekstra G, van Rosmalen J, Strackee S, Hovius S
J Hand Surg Eur Vol. 2020; 45(9):974-980.
PMID: 32746687
PMC: 7583439.
DOI: 10.1177/1753193420943400.
Automated synthesis, preclinical toxicity, and radiation dosimetry of [F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrier.
Toyohara J, Sakata M, Tago T, Colabufo N, Luurtsema G
EJNMMI Res. 2020; 10(1):84.
PMID: 32700099
PMC: 7376787.
DOI: 10.1186/s13550-020-00674-6.
A comparative study on image quality of two digital intraoral sensors-methodological, ethical and statistical issues.
Coelho-Silva F, Fontenele R, de-Azevedo-Vaz S, Freitas D
Dentomaxillofac Radiol. 2020; 49(4):20200054.
PMID: 32250660
PMC: 7213525.
DOI: 10.1259/dmfr.20200054.
Human biodistribution and radiation dosimetry of the 5-HT receptor agonist Cimbi-36 labeled with carbon-11 in two positions.
Johansen A, Holm S, Dall B, Keller S, Kristensen J, Knudsen G
EJNMMI Res. 2019; 9(1):71.
PMID: 31367837
PMC: 6669221.
DOI: 10.1186/s13550-019-0527-4.
Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [C]CS1P1.
Liu H, Laforest R, Gu J, Luo Z, Jones L, Gropler R
Mol Imaging Biol. 2019; 22(2):285-292.
PMID: 31165387
PMC: 6893109.
DOI: 10.1007/s11307-019-01380-z.
Ethical Conundrum in Nuclear Medicine Research in India.
Agrawal K, Meher B, Padhy B
Indian J Nucl Med. 2019; 34(2):83-85.
PMID: 31040516
PMC: 6481194.
DOI: 10.4103/ijnm.IJNM_171_18.
Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
Gerisch M, Hafner F, Lang D, Radtke M, Diefenbach K, Cleton A
Cancer Chemother Pharmacol. 2017; 81(1):195-206.
PMID: 29188322
PMC: 5754413.
DOI: 10.1007/s00280-017-3480-9.
Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism.
Christensen N, Jakobsen S, Schacht A, Munk O, Alstrup A, Tolbod L
Mol Imaging. 2017; 16:1536012117734485.
PMID: 29073808
PMC: 5665104.
DOI: 10.1177/1536012117734485.
